ProMed Pharma marks 1-year anniversary of new development and analytical labs

ProMed Pharma’s Product Development and Analytical Testing facility in Maple Grove, Minnesota [Image courtesy of ProMed Pharma]

NEWS RELEASE: ProMed Pharma celebrates one-year anniversary of new Maple Grove development and analytical laboratories

ProMed Pharma recently celebrated the first anniversary of the opening of its Product Development and Analytical Testing facility in Maple Grove, Minnesota.

The facility currently includes two state-of-the-art Class 7 clean rooms with dedicated air handling, gowning areas and a 2,500 sq/ft analytical laboratory.  The first suite is approximately 1,800 sq/ft and dedicated to supporting customer-funded early-stage development and feasibility projects using both injection molding and hot melt extrusion processes for producing sustain release products. The second suite presently houses late-stage clinical and commercial development activities using highly potent …

Read more
  • 0

ProMed Pharma begins preclinical testing of resorbable contraceptive implant

After receiving funding from the Bill & Melinda Gates Foundation, ProMed Pharma has begun preclinical evaluation of a novel fully resorbable contraceptive implant.

The Plymouth, Minnesota–based company imagines that the contraceptive implants could ultimately find use in low- and middle-income (LMIC) settings.

The novel implant potentially could offer women 18 months of contraception through the long-term release of levonorgestrel, a hormonal type of birth control first patented in 1960.

The fully biodegradable implant would also obviate the need for women to travel to medical clinics to have the device removed.

In addition, the device is designed to enable physicians to remove the device early, if needed.

A contract manufacturer of polymer-based drug releasing implantable silicone components,

Novel bioresorbable contraceptive implant developed at ProMed Pharma

ProMed h…

Read more
  • 0